[Laryngeal papillomatosis].
R P
RP
Viñals
D000293:Adolescent; D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D007231:Infant, Newborn; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D007822:Laryngeal Neoplasms / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000628:therapy; D008297:Male; D009361:Neoplasm Invasiveness; D010212:Papilloma / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000628:therapy; D027383:Papillomaviridae / Q000302:isolation & purification; D012008:Recurrence; D014412:Tumor Virus Infections / Q000150:complications / Q000382:microbiology
D000970:Antineoplastic Agents; D004279:DNA, Viral; D007372:Interferons
Papilomatosis laríngea.